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Abstract 
The mechanisms involved in tumor growth mainly occur at the microenvironment, where the 
interactions between the intracellular, intercellular and extracellular scales mediate the dynamics 
of tumor. In this work, we present a multi-scale model of solid tumor dynamics to simulate the 
avascular and vascular growth as well as tumor-induced angiogenesis. The extracellular and 
intercellular scales are modeled using partial differential equations and cellular Potts model, 
respectively. Also, few biochemical and biophysical rules control the dynamics of intracellular 
level. On the other hand, the growth of melanoma tumors is modeled in an animal in-vivo study 
to evaluate the simulation. The simulation shows that the model successfully reproduces a 
completed image of processes involved in tumor growth such as avascular and vascular growth 
as well as angiogenesis. The model incorporates the phenotypes of cancerous cells including 
proliferating, quiescent and necrotic cells, as well as endothelial cells during angiogenesis. The 
results clearly demonstrate the pivotal effect of angiogenesis on the progression of cancerous 
cells. Also, the model exhibits important events in tumor-induced angiogenesis like anastomosis. 
Moreover, the computational trend of tumor growth closely follows the observations in the 
experimental study. 
Keywords: Tumor Growth, Tumor-induced Angiogenesis, Multiscale Modeling, Cellular Potts 
Model, Animal Modeling 
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Introduction 
Nowadays cancer is one of the major threats to human life. Relying on this importance, many 
researches have studied the various aspects of tumors biology in order to obtain an understanding 
of the related mechanisms, and to predict optimal anti-cancer treatments. Procedurally, 
appearance and progression of solid tumors are the main dynamics of most cancers [1]. 
Accordingly during the last few decades, the mechanisms of solid tumor growth attract the 
attention of many cancer-related researchers [2]. Solid tumor is an unusual cell population 
appearing due to the lack of normal regulation on cells growth mechanisms, which consequently 
initiates excessive cells proliferation. During the first phase of tumor development, entitled 
avascular growth, due to the limitation of oxygen diffusion into living tissues, the concentration 
of oxygen is decreased around the tumor core cells. Consequently, the internal machine of each 
hypoxic, oxygen-deprived, cell switches the phenotype of the cell step by step from proliferating 
to quiescent, and finally to necrotic. In this situation, necrotic cells secrete a variety of pro-
angiogenic factors into the surrounding tissue [3], such as diverse types of growth factors, 
different types of regulator proteins like vascular endothelial growth factor (VEGF) [4]. 
However, these tumor angiogenic factors (TAFs) stimulate the microenvironment, particularly 
endothelial cells (ECs), and make it undergoing into the vascular phases of evolution [5]. All in 
all, vascular networks start to grow toward avascular tumor rely on complex amounts of 
signaling pathways [6] and a process so called tumor-related angiogenesis is begun [7]. 
Angiogenesis acts as a switch to reactivate quiescent cells and turns tumor growth phase from 
avascular to vascular. Generally, it has been demonstrated that tumor size in avascular phase is 
limited to a diameter of 1 to 2 millimeter and tumor cell population is limited [8], however, the 
tumor growth in absence of mechanical barriers or therapies is extremely progressive during the 
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vascular stage. Moreover, the tumor invasion and metastasis are more likely to happen in 
vascular stage.  
Mechanisms involved in tumor growth engages complex multicellular dynamics in different 
spatio-temporal scales including intracellular, intercellular and extracellular scales [9]. Despite 
the helpful understandings of tumor growth processes obtained by experiments tied up with 
recent imaging modalities [10, 11], it is hard to evaluate all the various multi-scale phenomena 
occurring during tumor growth in experimental studies. In this context, a multi-scale modeling 
embedding various spatio-temporal scales involving in tumor growth would make an acceptable 
sight of such intricate procedure.  
Mathematical Modeling of Tumor Growth 
Mathematical and computational approaches facilitate several strategies to rebuild the multi-
scale processes involved in tumor growth. Over the last two decades a number of computational 
models have been developed to investigate the nature of tumor growth. In several studies, 
continuous models act like a black box hiring a series of advection-diffusion-reaction equations 
to describe tumor dynamics in the border [12]. These models do not provide details on many 
important processes such as cellular interactions. On the other hand, discrete approaches consider 
the tumor as a population of interacting cells or agents [13] which have the ability to model 
important cellular functions like migration [14]. Accordingly, the discrete models, such as 
cellular automata (CA) approaches [15], obtain more naturalistic presentation of the process, 
which is more biologically desired too. However, the drawback of discrete modeling is the high 
computational cost. In the third approach, hybrid models exploit a combination of continuous 
and discrete models considering the optimized approach for each scale [16]. Also, it has been 
demonstrated that the integration of various spatio-temporal processes in a hybrid model usually 
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provides a solid context to simulate diverse multi-scale biological phenomena such as tumor 
growth.  
Hybrid models of solid tumor growth have been involved into three categories including 
avascular growth, tumor-related angiogenesis, and vascular growth. While the vascular growth is 
known as the hallmark of cancer progression [17], the majority of previous models, involving 
most of the multi-scale models, have solely studied the avascular growth [18]. In the most 
similar work to the current study regarding the modeling approach, Jiang et al. provided a hybrid 
frame work to monitor tumor growth during avascular stage [19]. Alemani et al. combined 
cellular automata (CA) with lattice Boltzmann method to model avascular tumor growth along 
with the immune system responses [20]. Also, Dormann and Deutsch modeled the tumor growth 
using the CA to simulate the growth of a self-organized avascular tumor [21], and recently 
Ghadiri and coworkers developed a multi-scale model of tumor growth based on an agent-based 
framework [22]. A comprehensive account of the mathematical models of avascular tumor 
growth and relevant literature is found in the works of Roose et al [23] and, Cristini and 
Lowengrub [24]. All in all, despite the mathematical and computational advances in the tumor 
growth modeling, these models due to lack of at least vascular phase simulation are inadequate. 
Hopefully in the recent years, the development of hybrid models offer a path toward the 
comprehensive as well as predictive modeling of tumor growth [25]. In the one of the most cited 
works on the vascular tumor modeling, Macklin and coworkers coupled a model of tumor 
growth with a model of tumor-induced angiogenesis to study the vascular remodeling [26]. 
Shirinifard et al presented a multi-cell simulation of a generic simplification of vascular tumor 
growth [27]. Lesart and coworkers combined a computational model with a mouse model to 
investigate the effects of vascular network during tumor development [28]. Tang et al. simulated 
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the tumor growth affected by angiogenesis using a system of partial differential equations [29]. 
Also, Xu et al using phase fields and a reaction diffusion equation simulated the tumor growth 
coupled with angiogenesis [30]. The articles of Oden et al. [25] along with Ng and Frieboes [18] 
study provide a full background on multi-scale modeling of vascular tumor.  
Although the achievements of previous works would be considered as a big step for the 
development of a multi-scale in-silico model of tumor growth, previous models hardly hold to be 
a comprehensive one because of at least one of the following reasons. Firstly, they often have not 
gathered together the three major phases of tumor growth including avascular growth, 
angiogenesis and vascular growth. Moreover, the majority of previous studies have been used 
prescribed rules in the all aspects of modeling which eliminate the originality of the results. In 
the current study, we present a comprehensive multi-scale model of solid tumor growth that 
simulates avascular and vascular tumor growth as well as tumor-induced angiogenesis using no 
prescribed rules except elementary dynamics in the intracellular environment. We developed a 
hybrid model which a cell-based model, cellular Potts model (CPM), describes the cellular 
dynamics in the microenvironment, and two partial differential equations (PDEs) evolve oxygen 
and TAF diffusion in the domain.  
Materials and methods 
Animal Experiments 
All the experimental procedures, including what has related to the development, sampling and 
testing murine cancer models were taken place in the animal lab of Cancer Biology Research 
Center (CBRC) of Tehran University of Medical Sciences (TUMS) that is placed in Imam 
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Khomeyni Hospital Complex. Indeed, CBRC obtained the TUMS Cancer Research Center’s 
(CRC) approval for all protocols were followed in this article in the way of ethical code. 
Tumor model 
Three Male C57Bl/6 mice, 12 weeks of age and approximately 20 up to 26 gr of weights, were 
purchased from Advanced BioModel Co/ P. B16/F10 (CRL-6475) Melanoma cells line were 
obtained from Pasture Institute of Iran. Cells were cultured in DMEM + 10% FBS + 2mML-
Glutamine with the concentration of 1×    cells/100 µl and 20 ul of the cultured media were 
injected subcutaneously. This way, mice were anaesthetized by peritoneum injection of ketamine 
80-100 mg/kg and xylazine 10-12.5 mg/kg. After 15 days, palpable tumors were touched under 
mice skins. Mice were sacrificed in the day 15 using cervical dislocation method. The tumors 
were excised and sliced into small pieces. Syngeneic transplantations were conducted using three 
other C57Bl/6 using these slices. For the sake of the transplantation, mice were chosen from 
similar strains and anaesthetized in similar protocol depicted above. Sliced tumors were 
transplanted intracutaneously using a pair of forceps. The mice tumor’s evolutions were analyzed 
every three days for the period of one month using digital caliper every 3 days after 
transplantation and the table 1 shows the results.  
Table 1. Tumor sizes measurement in the period of 30 days for 3 mice of control. 
 MOUSE 1 (   ) MOUSE 2 (   ) MOUSE 3 (   ) AVERAGE 
DAYS 3 44.1 28.2 49.7 40.7 
DAYS 6 116.1 25.9 152.8 98.3 
DAYS 9 45.6 218.9 242.5 169 
DAYS 12 16.9 50.3 88.9 52 
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DAYS 15 153.2 1045.3 708.6 635.7 
DAYS 18 120.6 1077.4 2098.5 1098.8 
DAYS 21 567.5 1951.1 6495.1 3004.6 
DAYS 24 711 3972.5 9805.3 4829.6 
DAYS 27 1599.3 6176.4 12902 6892.6 
DAYS 30 2923.5 11760.9 16651.2 10445.2 
Multi-Scale Modeling of Tumor Growth 
Our multi-scaled model couples angiogenesis and tumor growth and it evolves the processes in 
three levels which are the extracellular, intercellular and intracellular levels. Accordingly, at the 
extracellular level, nutrients diffuse from the nearby parent vessels, and make a gradient in the 
tumor surrounding tissue. Also, during angiogenesis phase, the hypoxic cells in the center of fast 
proliferative tumor cells mass secrete the TAF into extracellular environment. Consequently, at 
the intracellular level, the mechanical and chemical signals actuate the internal machine of each 
cell, including cancerous cells and tumoral endothelial cells, to change the cells’ phenotype. 
Finally, at the intercellular level, cells activation including cancerous cells proliferation and, ECs 
proliferation and migration occurs. 
At the extracellular level a diffusion-reaction equation controls oxygen diffusion into nearby 
tissue and also, it calculates oxygen consumption of cancerous cells [16]. Moreover, the 
concentration of TAF is calculated by a diffusion equation. At the cellular level, tumor is treated 
as a mass of agents. Also, the process of sprouting angiogenesis depends on endothelial cells 
dynamics. Accordingly, the cellular Potts models (CPM) is employed to reproduce cellular 
interactions in the model. CPM is a cell-based model working according to energy minimization 
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principle that was developed by Glazier and Graner [31]. In CPM, based on the Hamiltonian 
which is corresponded to total energy in the system, Hamiltonian terms describe the cellular 
dynamics in the model. Accordingly, each lattice total energy is calculated in each time step to 
decide what change in the lattice configuration is acceptable. Mainly, Intercellular interactions 
occur only at the cell’s surface. Therefore, the main machine of CPM are the surface fluctuations 
of cells controlling by the Hamiltonian [32].  
Model Domain and Geometry 
The computational domain is a cube with a side of 15 mm, which at the onset of simulation 
thousand tumor cells are located at the center of domain, ready to grow in respect to available 
amount of oxygen. Also, during the initiation of vascular phase, the angiogenic sprout would 
grow form the parent vessel locating on the domain sides. The avascular tumor in the earliest 
phase of growth consists of proliferating cells. As tumor grows, due to oxygen deficiency in the 
center of tumor, hypoxic cells have to change their phenotype from proliferating to quiescent. 
However, peripheral tumor cells still proliferating and tumor growth is not halted at this stage. 
After a while, the quiescent cells die, and necrotic core is generated. Subsequently, hypoxic cells 
release angiogenic factors to stimulate nearby vessels to actuate sprouting angiogenesis. 
Consequently, after sprouts maturation, the growth of new formed vasculature increases the 
amount of oxygen and nutrients around hypoxic region. After reaching a threshold for triggering 
cellular growth, quiescent cells are activated, and starts to growth exponentially. Fig. 1 illustrates 
a schematic design of the computational domain. 
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Figure 1: Model domain and its component. Necrotic core (gray), quiescent cells (blue) and proliferating cells (red) 
are located in the tumor matrix.  
 
Extracellular Level 
Cancerous cells are in a tight interaction with surrounding microenvironment. The 
microenvironment dynamics is controlled by the amount of certain biochemical substances. 
During tumor growth, the main regulatory substances are TAF as well as oxygen and glucose 
which in the literature is denoted by nutrients. In the current model, the available amount of 
oxygen for each cell in the surrounding decides the cancerous cells phenotype. Mathematically, a 
diffusion-reaction equation is able to describe the diffusion of oxygen in the domain as follows 
[17]. 
2
2 ( , , )O
V
D V C x y z
t

  

 (1) 
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In equation (1), V (x, y, z, t) is the concentration of oxygen in domain. 
2O
D is the oxygen 
diffusion constant which it has a positive and homogenous value all over the domain. C is the 
consumption rate of oxygen by cancerous cells, which varies depending on the tumor cells 
phenotypes. The C defines as following [17] 
0
T
O T
V V
C C
V V


  
(2) 
In equation 2, C0, V
O
 and V
T
 respectively are initial oxygen consumption rate, oxygen optimize 
concentration and oxygen threshold concentration [17].  
In this level, oxygen diffuses though extracellular matrix (ECM), which in the current modeling, 
the ECM was modeled implicitly. Also, the diffusion constant has same value all over the 
domain including. Considering these simplifications, the boundary conditions on the tumor will 
be [17];  
OV V  (3) 
During angiogenesis, TAF is secreted into the ECM by tumor hypoxic cells. The TAF has 
constant decay rate and it uptakes by ECs [9]. The below diffusion equation describes the TAF 
dynamics in the domain: 
2
( , , )TAF
V
D V V B x y V
t


   
  
(4) 
where V (x, y, t) denotes the TAF concentration and TAFD , λ, and B are the TAF diffusion 
coefficient, TAF decay rate, and TAF uptake function, respectively. The coefficient of diffusivity 
for TAF in tissue, TAFD > 0, is assumed to be constant all over the simulation domain. The rate of 
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TAF decay, λ > 0, is also assumed to be constant, and B (x, y, V) is a function that defines the 
amount of TAF uptake by each EC [9]. The uptake function is [9]; 
, )
( , ) ,
( ,
( , ) , 0
V
if V
x y EndothelialCell
B x y V if V
x y EndothelialCell
 






 
 


 
(5) 
In Eq. 5, β is the maximum amount of TAF which can be bound to an EC’s receptors. At first 
there is no amount of TAF till the cancerous cells become hypoxic. Procedurally, the TAF source 
reaches a constant concentration denoted with S [9].  
At the onset of simulation, it is assumed that oxygen concentration is constant at the domain. At 
avascular phase, growing cells consume available oxygen and hence, the concentration of 
oxygen decreases around the tumor. Consequently, the released TAF actuate the angiogenesis 
process, and a new vascular network forms around tumor. Accordingly, at this vascular stage, 
growing vasculatures bring new supply of oxygen which help quiescent cells to survive and, 
proliferate.   
Cellular Level 
Cells are the main machine in cellular level of cellular Potts model (CPM). In this level the main 
approach for capturing cellular dynamics is to set an energy, based on Hamiltonian, for each 
distinct physiological phenomena occurring at the cell-cell interaction. 
In the CPM lattice, matrix, necrotic core and quiescent cells IDs are 0, 1 and 2 respectively. 
Also, each proliferating cell has unique ID number starting from 3. Moreover, during 
angiogenesis, each EC is identified in the model with a specific ID. Fig. 2 shows a typical 
configuration of CPM lattice.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
13 
 
 
Figure 2: Typical 2D configuration of the domain lattice in CPM. The light gray (m), green (e), red (p), blue (q) and 
dark gray (n) pixels are tumor surroundings matrix, proliferating, quiescent and necrotic cells, respectively.  
The main biological phenomena controlling the cellular environment during tumor growth are 
cells adhesion, growth and migration. Cell adhesion is a key biological characteristic for 
preserving multicellular structures. Cellular adhesion is core of many morphogenetic processes 
regulating mechanical interactions between cells. For instance, cell migration and cell sorting are 
samples of important morphogenetic processes controlling by the cellular adhesion molecules 
[33]. The adhesion energy comes from hydrogen and ionic bonds that keep cells and their 
adhesion cooperative together [9]. The mechanical role of adhesion is to provide the requisite 
energy needed for the cohesive attachment of cells to their surroundings, this energy can be 
described as following 
' , ',
(1 )adhesion
domain
E J   
 
 
(6) 
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J is the adhesion energy between two entities τ and τ’. σ and σ’ are numbers of two adjacent 
lattice sites and δ is the Kronecker delta. Kronecker delta has nonzero value only in lattice sites 
with different cells type in the neighborhood. 
Generally in absence of any treatment and physical barrier, Cancerous and endothelial cells grow 
until reach the maximum size called target volume. After reaching the target volume, the cells 
will be entering into mitosis cycle and each mature cell is divided into two separate cells. The 
next energy term provide cell growth and cell deformation required energy [19]:  
2
( )
T
volume
cells
E a A
  
 
(7) 
In equation (5) aσ is the current volume of cell and Aσ
T
 is the target volume of the each cell. γτ is 
the resistance of cells to the volume change that is interpreted as cells elasticity. We assume that 
without any other external forces and ample nutrition, the cancerous cells would grow until 
getting double of its initial volume, which sets as the target volume. As far as cell volume is less 
than the target volume, every change in the cell that increases its volume, reduces the total 
energy of the system and helps to accept the change in the lattice configuration.  
To keep pixels continuity in a unique cell, another Hamiltonian term is considered in the total 
energy to avoid cell rupturing during migration and proliferation. Accordingly, if the summation 
of pixels’ volume for each cell (aσ) would not equal the summation of continuous pixels’ volume 
of that cell (aσ’), the total energy increased drastically by the following term and prevent any 
change in system [9]:  
',
(1 )continuity a a
cells
E
 
  
 
(8) 
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In the above equation α is continuity constant which its value is noticeably high.  
In the model, cancerous cells interactions could be modeled through Hamiltonian by 
combination of adhesion, growth and continuity energies. 
TumorGrowth adhesion volume continuityE E E E    (9) 
At the onset of vascular stage, endothelial cells of nearby vessels are induced by TAF to migrate 
toward the tumor by chemotaxsis strategy. Chemotaxis mainly is determined by the TAF 
gradient in the domain. Therefore, a simple relation between chemotaxis and TAF gradient could 
indicate its contribution to total energy. Haptotaxis is the directed movement of cells controlled 
by the relative connection due to peripheral cells adhesions. Since the different adhesion energies 
are considered between entities, the model inherently contains haptotaxis energies [9]. Due to 
chemotactic migration, ECs move in the direction of increasing TAF concentration. 
Phenomenologically, chemotaxis speed has a proportion to the TAF gradient. Consequently, 
chemotactic force is proportional to the chemical gradient [34], and it is possible to construct a 
proper chemotaxis energy, that is proportional to the local chemical gradient as follows, 
chemotaxis
domain
E V   
(10) 
where χσ is the effective chemical potential of ECs and ΔV is the TAF gradient. The response of 
ECs and Tip cells to chemotaxis stimuli is different. Thus, different effective chemical potentials 
are considered for ECs and Tip cells in the model. 
Considering the nature of angiogenesis process, the interaction between ECs and tumor can be 
described as below 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
16 
 
Angiogenesis adhesion volume chemotaxis continuityE E E E E     (11) 
Every changes in the lattice configuration is based on a simple rule that ensures system 
randomness. Procedurally, a lattice site, (i, j), is selected at random, and one of the unlike nearest 
neighbors, (i’, j’), is selected randomly. The total energy of the system is computed before and 
after any proposed update in lattice. If the total system energy is reduced due to the change, it is 
accepted [35]; otherwise, the update is accepted with a Boltzmann probability [9] 
tan exp 0
total
accep ce
E
P E
kT

  
 
 
   
(12) 
Where k is the Boltzmann constant and T is a measure of system disorder or cell membrane 
fluctuations.  
Intercellular Level 
In this scale, the model considers few rules between extracellular and intercellular levels for the 
following cellular behaviors. For cancerous cells, oxygen vital threshold along with the 
competition between cells for acquiring space to grow determine the phenotype of each cell 
[19,36]. Accordingly, in the model, if a tumor cell does not grow in a time equal to the average 
time for a tumor cell to grow one pixel, the cells phenotype changes to quiescent, and cellular 
growth is stopped. Afterwards, if the oxygen concentration gets below a vital threshold, denoted 
with tv, quiescent cells die via necrosis, and angiogenic signaling is initiated by necrotic cells 
[37].  
Model Parameters 
In current model, the physiologic and physical properties for various cells type are different 
including cell cycle stage, metabolism rate, cellular adhesion and cells target volume. As 
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surrounding matrix pixels has no target volume, peripheral cancerous cells can easily evade and 
growth in this environment. Also, target volume of necrotic cells is equal to the last volume of 
cells before necrosis.  
A list of all parameter values used in our model provided in Table 2. Generally, the parameter 
values involved in the reaction-diffusion equation obtained from empirical data sets [38-44]. 
Since there is no available experimental value for the parameters involved in the cell-based 
model, they were manually tuned to emulate observed phenomenological behaviors, and to 
follow the experimental results. However, the range of parameters tuning adopted from the 
experiments, and basic biological knowledge [19]. Accordingly, cellular bounds indicates that 
the binding between two ECs or two cancerous cells is much stronger than binding of any other 
constituent types in the EC-ECM or tumor cell-ECM interactions [9, 19]. Also, regarding the 
binding of tumor cells, due to low impact of cellular adhesion in the model comparing to growth 
and proliferation affinities, there would no significant impact by choosing other values [19]. The 
values of membrane elasticity is defined somehow to reflect the natural deformation of each cell 
during growth. For instance, the elasticity constant of necrotic cells is assumed relatively high in 
order to express necrotic core as a solid body.  
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Table 2. Values of model’s constants 
Parameter Symbol Dimensions Model Value 
Length Scales L1,2,3 L 3000µm 
Oxygen Diffusion Do2 L
2
/T 1.65˟10
3
 µm
2
/s [38,39] 
Initial Consumption of Proliferating 
Cells 
C0-P M/T/L
3
 8.97 ˟10
-9 
pg/s/voxel [40] 
Initial Consumption of Quiescent Cells C0-Q M/T/L
3
 4.15 ˟10
-9
 pg/s/voxel [40] 
Initial Consumption of Necrotic Cells C0-N M/T/L
3
 0.00 pg/s/voxel 
Vital Threshold tV M 4.48 ˟10
-3
 pg/voxel [41] 
TAF Diffusion DTAF L
2
/T 0.1 µm
2
/s [42] 
TAF Decay λ T
-1
 1.8˟10
-4
 s
-1
 [42] 
TAF uptake β M/cell/T 1.66˟10
-5
 pg/EC/s [43] 
TAF Source S M/L 0.035 pg/voxel [44] 
Activation Threshold νa M 0.0001 pg [7] 
Proliferating-Matrix Adhesion Jpm E/L 16 [19] 
Quiescent-Matrix Adhesion Jqm E/L 14 [19] 
Necrotic-Matrix Adhesion Jnm E/L 12 [19] 
Proliferating-Proliferating Adhesion Jpp E/L 28 [19] 
Proliferating- Quiescent  Adhesion Jpq E/L 28 [19] 
Proliferating-Necrotic Adhesion Jpq E/L 24 [19] 
Quiescent- Quiescent Adhesion Jpn E/L 28 [19] 
Necrotic-Necrotic Adhesion Jqq E/L 24 [19] 
Quiescent-Necrotic Adhesion Jnn E/L 22 [19] 
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EC-EC Adhesion Jqn E/L 30 [46] 
EC-Matrix Adhesion Jee E/L 66 [47] 
Matrix-Matrix Adhesion Jem E/L 85 [46] 
Proliferating Cells Elasticity γp E/L
4
 2  
Quiescent Cells Elasticity γq E/L
4
 8  
EC Membrane Elasticity γe E/L
4
 0.8 [45] 
Chemotactic Sensitivity χ E/conc. 1.1˟10
6 
[45] 
Boltzmann Temperature kT E 2.5 [9] 
 
The sensitivity analysis of parameters is conducted by changing one parameter value fixing other 
parameters involved in the modeling.  Accordingly, the results show by choosing relatively 
smaller values for adhesion energies (Jτ,τ’) than the reported values in Table 2, generally the cells 
bonds become stronger. However, it unrealistically simulates the cells shapes, elongation and 
especially sprouts morphology. On the other hand, greater values of adhesion energies decrease 
the cellular contacts disintegrating the cells adhesive connections. Particularly doubling the 
adhesion value for endothelial cells, Jee = 60, splits up the endothelial cells during sprouting. 
Moreover, it fades the migration cues of endothelial cells during haptotactic migration. 
Regarding the elasticity constants (γτ), any smaller value than the current measure accelerates the 
growth speed of all type of cells and subsequently it increases the size of tumor. However, this 
forces the cells to deviate the target volume, which is not biologically acceptable. Greater 
amount of elasticity also makes cellular growth harder which reduces the growth rate, and 
increases the time of computation. Regarding the effect of chemotactic sensitivity value on the 
model, a smaller value like χ= 1˟104 decreases the chemotaxis potency during ECs migration and 
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fails the sprouting angiogenesis. Otherwise, a larger value of chemotactic sensitivity endangers 
the ECs continuity during migration. The value of kT affects the membrane fluctuations of cells 
in the model. Accordingly, the higher values increase the membrane fluctuations, and smaller 
values decrease the membrane fluctuations in the simulation. 
Results and Discussion 
The simulation initiates with a tumor consists of thousand cancerous cells. Also, at the beginning 
of angiogenesis, 36 single endothelial from four parent vessels cells appears at the border of the 
domain receiving the signal from TAF stimulation, and they are lined up for migration toward 
tumor. In another word, after uptaking the TAF by ECs, they start to grow, proliferate and 
migrate toward the hypoxic cells. The results are presented in two major parts. Firstly, the 
evolution of tumor in avascular phase, in the absence of adequate nutrients, is presented. 
Subsequently, the results of avascular growth are evaluated by the experimental results adopted 
from Jiang et al work [17]. In the next part, the simulations of tumor growth promoted by the 
angiogenesis process is demonstrated.  Fig. 3 shows the earliest growth of avascular tumor in the 
first four days. Results in Fig. 3 illustrate that this cluster of tumor cells feeding from the 
available nutrients in the surrounding grows up to ten times in just first four days.  
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Figure 3: The avascular tumor is growing ten times in the first four days of modeling. The simulation starts with a 
cluster consists of thousand proliferating cancerous cells (the red cluster) located at the center of domain.  
Fig. 4 illustrated the formation of quiescent cells in the inner part of tumor spheroid .After a 
while, peripheral cells in the tumor spheroid consume oxygen in the environment, and decrease 
the oxygen diffusion to central parts of tumor. Moreover, the physical challenges between 
peripheral and inner cells for growth prevent inner core tumor cells from growing. As a result of 
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these conditions, the substantial part of inner cells changes their phenotype to quiescent. In Fig. 
4, it is possible to observe that the interface between quiescent and proliferating cells moves 
continuously toward tumor surface. Also, even though the gradient of tumor growth is slower in 
this situation, however, tumor pursue its growth up to four times.  
 
Figure 4: Multiple scenes of tumor growth in second four days. Central cells due to oxygen shortage turn from 
proliferating (red) to quiescent (blue) cells.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
23 
 
After cell quiescence, due to severe oxygen shortage in the tumor core cells, necrosis is occurred. 
Considering this theory, in the model necrosis occurs when the oxygen concentration does not 
satisfy oxygen vital threshold (tv). In Fig. 5, the third four days of tumor growth is shown, which 
the necrosis occurs in day 10. Results show that by forming the necrotic core in avascular phase, 
tumor does not grow more than five percent per day. 
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Figure 5: Multiple scenes of tumor growth in third four days. Along with oxygen shortage consistency, quiescent 
cells (blue) die and necrotic core (gray) is formed.  
It is possible to evaluate the trend of tumor growth produced by the model with an experiment 
conducted by Jiang et al [17] in Fig. 6. The comparison demonstrates that the computational 
results, considering the model simplifications, nearly follows the experimental observation.  
  
         Figure 6: Tumor growth in avascular phase.  
After necrotic core formation, secreted TAF by hypoxic cells ignites angiogenesis, and 
accordingly, new growing sprouts provide essential supply such as oxygen to resume tumor 
accelerating growth [48]. Based on the results from the in-vivo model, in the computational 
model it is assumed that after 15 days of avascular growing, sprouting angiogenesis begins. Also, 
considering the experiment set up, at onset of vascular phase, the tumor diameter is around 2 
mm. In Fig. 7, initial phase of tumor vascular growth is shown in the three days periods. Fig. 7 
illustrates that due to local oxygen concentration increases, proliferating cells accelerate their 
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growth. However, pay attention that the quiescent region is still developing (Fig. 7). 
Consequently, the proliferating cells gain the required oxygen supply for unleashed growing, and 
by these mean, the activated quiescent cells found the opportunity to grow and proliferate due to 
reducing physical stresses in the surrounding. Fig. 9 shows the computational results on day 15
th
 
to day 24
th
 of vascular tumor growth. Results for day 15
th 
and 18
th
 prove that the quiescent cells 
are activating, and switching to proliferating phenotype. Subsequently, the tumor size increases 
more than twice in just these three days. Finally, must of the quiescent cells start to grow again 
which made the tumor growth gradient rises dramatically (Fig. 9).  
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Figure 7: Tumor growth during a 12 days period after initiation of angiogenesis. Sprouts grow toward tumor and 
also, the oxygen concentration locally rises.  
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Fig 8 depicts that the anastomosis, which in the connection of at least two sprouts, is happening 
during angiogenesis. In Fig. 9 the computational results on vascular tumor growth are compared 
with the one of the experimental observations. Accordingly, Fig 9. Shows that the model 
successfully is able to reproduce the trend of the solid tumor growth.  
 
Figure 8: Tumor growth during second 12 days of vascular growth. After tumor vascularization, tumor starts to 
grow exponentially.  
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Figure 9: A diagram on tumor vascular growth. Considering the simplifications and assumptions in the 
computational model, the trend of numerical results (red line) show a good convergence with the experimental 
results.    
 
Conclusions 
Clinical evidences shown that the growth of a tumor is in two different phases. While avascular 
growth of tumors is likely to be benign, the vascular tumor is malignant and ignites tumor 
invasion. In this study by using a comprehensive multi-scale model, a realistic model for tumor 
growth has been developed. Considering the nature of a solid tumor, the cellular environment of 
tumor was modeled in respect to the various cells phenotype including proliferating, quiescent 
and necrotic cells. Also, the model successfully simulated the complete process of tumor growth 
including avascular growth, angiogenesis and vascular growth. Moreover, the model coupled the 
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three interconnected level including extracellular, cellular and intracellular levels by 
implementing biologically desired approaches. At the extracellular level, PDEs described the 
oxygen and TAF diffusion in the domain. At the cellular level, CPM simulated the cellular 
dynamics in tissue microenvironment. Finally, at the intracellular level, few biophysical and 
biochemical rules controlled each cell internal machine. The results incorporate that angiogenesis 
is the main reason toward increasing growth rate at vascular phase. Accordingly, comparing with 
vascular tumor growth, avascular tumor growth rate is negligible. Furthermore, we evaluated the 
computational model in vascular stage using an in-vivo model. Although the model consists of a 
series of simplifications and assumptions, however, the final results shown a good coherence to 
the experimental observations as well as prior computational models. Also, the simulation was 
based on a biologically desired modeling, which considering the governing role of 
microenvironment on cancer dynamics, the current model would enable us to examine the effect 
of therapeutic mechanisms such as chemotherapy and radiotherapy on the tumor cellular 
dynamics.  
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“Highlights” 
 
 Modeling the major phases involved in tumor growth including avascular and vascular 
growth as well as angiogenesis. 
 
 The modeling strategy is multi-scale, and it covers extracellular, intercellular and 
intracellular dynamics. 
 
 
 An animal study confirms the ability of the model to simulate solid tumor growth. 
 
 As the simulation and in-vivo experiment shows, the progression of tumor is highly 
depends on the angiogenesis process.  
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